For: | Inoges S, Cerio ALD, Villanueva H, Pastor F, Soria E, Bendandi M. Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses. World J Clin Oncol 2011; 2(6): 237-244 [PMID: 21773074 DOI: 10.5306/wjco.v2.i6.237] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v2/i6/237.htm |
Number | Citing Articles |
1 |
Ahsan Naveed, Sajjad Ur Rahman, Muhammad Imran Arshad, Bilal Aslam. Recapitulation of the anti-Idiotype antibodies as vaccine candidate. Translational Medicine Communications 2018; 3(1) doi: 10.1186/s41231-018-0021-4
|
2 |
|
3 |
A. Allegra, S. Russo, D. Gerace, L. Calabrò, V. Maisano, V. Innao, C. Musolino. Vaccination strategies in lymphoproliferative disorders: Failures and successes. Leukemia Research 2015; 39(10): 1006 doi: 10.1016/j.leukres.2015.08.001
|
4 |
Jiawei Wang, Jiyuan Yang, Jindřich Kopeček. Nanomedicines in B cell-targeting therapies. Acta Biomaterialia 2022; 137: 1 doi: 10.1016/j.actbio.2021.10.024
|